RepliTope™ peptide microarrays are off-the shelf peptide microarrays, displaying overlapping peptide scans through antigenic proteins. RepliTope™ peptide microarrays are reliable and efficient tools for screening assays such as the characterization of potential therapeutic antibodies, the identification of novel biomarkers, and the elucidation of protein/protein and enzyme/substrate interactions. Additionally, we offer our comprehensive Peptide Microarray Assay and Incubation Service for outsourcing of experiments.
Standard RepliTope™ Peptide Microarrays for Infectious Diseases (for 1 sample)
Multiwell RepliTope™ Peptide Microarrays for Infectious Diseases (for 21 samples)
RepliTope™ Antigen Collection Catalog Peptide Microarrays
Standard RepliTope™ Peptide Microarrays for Tumor Associated Antigens (for 1 sample)
Multiwell RepliTope™ Peptide Microarrays for Tumor Associated Antigens (for 21 samples)
Incubation Kit & Accessories
- Screening of seromarkers for infectious and autoimmune diseases, allergies and cancer
- Development of phosphorylation dependent antibodies
- Epitope mapping using only minimal amounts of antibody
- Individual or parallel antibody profiling
- Profiling of neutralizing antibody action
- Immune Monitoring of humoral immune responses during clinical trials
The Challenge of Antigen Sequence Diversity: Solutions with ULTRA‐Peptide Libraries
by Reimer et al.
Multiple Sclerosis and Epstein‐Barr Virus Infection. An Epitope Mapping Study
by Reimer et al.
Antibody Signatures Defined by High-content Peptide Microarray Analysis
by Schutkowski et al.
"One focus of our group is to decipher the nature of immune responses by identification of biomarkers and indicators of immune protection. With the support of JPT's high content peptide microarray platform, we created a peptide chip which contains 22.000 individual peptides. This enabled the visualization of the B-cell "signature" in individuals with TB-infection vs. non- infected individuals. In our hands, JPT's peptide microarrays turned out to be very robust tools to identify novel peptide based biomarkers in the context of novel diagnostics and vaccine target identification."
Prof. Markus Maeurer, Karolinska Institute Sweden, Solna, Sweden
Immune Checkpoint Inhibitors
We launch new PepMixes™ and RepliTopes™ representing immune checkpoint inhibitors hPD-1, PD-L1, PD-L2 and CTLA4!
Address Sequence Diversity
with NEW ULTRA Peptide Microarrays for HIV and Malaria
A New Peptide Approach to meet Antigen Sequence Diversity
Browse our Ultra Catalog Products and read about the ULTRA algorithm (Nov 2017)